Literature DB >> 20172753

Association of variant alleles of MBL2 gene with vasoocclusive crisis in children with sickle cell anemia.

T F Mendonça1, M C V C Oliveira, L R S Vasconcelos, L M M B Pereira, P Moura, M A C Bezerra, M N N Santos, A S Araújo, M S M Cavalcanti.   

Abstract

Vasoocclusive crisis (VOC) is the major cause of morbidity and mortality in sickle cell anemia (SCA), which is caused by the occlusion of blood vessels, followed by ischemia or infarct, resulting in progressive damage to organs. However, this clinical manifestation is variable, indicating that this process could be influenced by modifier genes. The gene MBL2 which codes for mannose-binding lectin (MBL) has been associated with modifications in the progression of infectious and inflammatory vascular diseases. The aim of this study was to determine the frequency of the polymorphisms of exon 1 (alleles A/O) and promoter region -221 (alleles Y/X) of MBL2 in children with SCA and to verify their association with VOC. The determination of the polymorphism of exon 1 and the promoter region of MBL2 was performed by SYBR GREEN((R)) and Taqman((R)) system, respectively. In the patients with SCA, the frequency of the genotype related to high production of MBL was 0.46 (YA/YA) and for intermediate/low production was 0.54 (YA/XA, XA/XA, YA/YO, XA/YO, YO/YO). The frequency of the genotypes and haplotypes of MBL2 in patients with SCA did not differ from control individuals. The populations were in Hardy-Weinberg equilibrium. The patients were divided into two groups. The groups were separated by the frequency of VOC, which was defined by the total of VOC episodes divided by the age of the children at the end of this study. Since, we choose a cut point in FVOC <1 (n=48) (which we considered of mild presentation of disease) and FVOC >or=1 (n=39) (higher severity). In children with SCA, the frequency of the genotypes of MBL2 of intermediate/low expression for MBL was associated with FVOC >or=1 (p=0.0188 OR=3.15 CI=1.19-8.50). The results suggest that MBL2 polymorphism at promoter and first exon of MBL2 associated with low serum levels and structural alterations of MBL could modify the phenotype of the child with SCA related to VOC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20172753     DOI: 10.1016/j.bcmd.2010.02.004

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  11 in total

Review 1.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 2.  Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.

Authors:  Steven R Goodman; Betty S Pace; Kirk C Hansen; Angelo D'alessandro; Yang Xia; Ovidiu Daescu; Stephen J Glatt
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27

3.  Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.

Authors:  Ambroise Wonkam; Khuthala Mnika; Valentina J Ngo Bitoungui; Bernard Chetcha Chemegni; Emile R Chimusa; Collet Dandara; Andre P Kengne
Journal:  Br J Haematol       Date:  2017-12-03       Impact factor: 6.998

Review 4.  The search for genetic modifiers of disease severity in the β-hemoglobinopathies.

Authors:  Guillaume Lettre
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  Glucocorticoid receptor single nucleotide polymorphisms are associated with acute crisis pain in sickle cell disease.

Authors:  Ellie H Jhun; Nilanjana Sadhu; Yingwei Yao; Ying He; Robert E Molokie; Diana J Wilkie; Zaijie Jim Wang
Journal:  Pharmacogenomics       Date:  2018-08-06       Impact factor: 2.533

Review 6.  Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.

Authors:  Alawi Habara; Martin H Steinberg
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-01

7.  Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell disease.

Authors:  Ellie H Jhun; Yingwei Yao; Ying He; A Kyle Mack; Diana J Wilkie; Robert E Molokie; Zaijie Jim Wang
Journal:  Pharmacogenomics       Date:  2015-11-10       Impact factor: 2.533

8.  Single Nucleotide Polymorphisms at +191 and +292 of Galectin-3 Gene (LGALS3) Related to Lower GAL-3 Serum Levels Are Associated with Frequent Respiratory Tract Infection and Vaso-Occlusive Crisis in Children with Sickle Cell Anemia.

Authors:  Taciana Furtado de Mendonça Belmont; Kleyton Palmeira do Ó; Andreia Soares da Silva; Kamila de Melo Vilar; Fernanda Silva Medeiros; Luydson Richardson Silva Vasconcelos; Ana Claudia Mendonça Dos Anjos; Betânia Lucena Domingues Hatzlhofer; Maíra Galdino da Rocha Pitta; Marcos André Cavalcanti Bezerra; Aderson da Silva Araújo; Moacyr Jesus Barreto de Melo Rego; Patrícia Moura; Maria do Socorro Mendonça Cavalcanti
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

Review 9.  Genomic approaches to identifying targets for treating β hemoglobinopathies.

Authors:  Duyen A Ngo; Martin H Steinberg
Journal:  BMC Med Genomics       Date:  2015-07-29       Impact factor: 3.063

10.  Impact of Mannose-Binding Protein Gene Polymorphisms in Omani Sickle Cell Disease Patients.

Authors:  Mathew Zachariah; Shoaib Al Zadjali; Wafa Bashir; Rahma Al Ambusaidi; Rhea Misquith; Yasser Wali; Anil Pathare
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-02-15       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.